Contrast Enhanced Ultrasound Molecular Imaging of Spontaneous Chronic Inflammatory Bowel Disease in an Interleukin-2 Receptor α-/- Transgenic Mouse Model Using Targeted Microbubbles
- PMID: 35055297
- PMCID: PMC8779209
- DOI: 10.3390/nano12020280
Contrast Enhanced Ultrasound Molecular Imaging of Spontaneous Chronic Inflammatory Bowel Disease in an Interleukin-2 Receptor α-/- Transgenic Mouse Model Using Targeted Microbubbles
Abstract
Inflammatory bowel disease (IBD) is a lifelong inflammatory disorder with relapsing-remission cycles, which is currently diagnosed by clinical symptoms and signs, along with laboratory and imaging findings. However, such clinical findings are not parallel to the disease activity of IBD and are difficult to use in treatment monitoring. Therefore, non-invasive quantitative imaging tools are required for the multiple follow-up exams of IBD patients in order to monitor the disease activity and determine treatment regimens. In this study, we evaluated a dual P- and E-selectin-targeted microbubble (MBSelectin) in an interleukin-2 receptor α deficient (IL-2Rα-/-) spontaneous chronic IBD mouse model for assessing long-term anti-inflammatory effects with ultrasound molecular imaging (USMI). We used IL-2Rα-/- (male and female on a C57BL/6 genetic background; n = 39) and C57BL/6 wild-type (negative control; n = 6) mice for the study. USMI of the proximal, middle, and distal colon was performed with MBSelectin using a small animal scanner (Vevo 2100) up to six times in each IL-2Rα-/- mouse between 6-30 weeks of age. USMI signals were compared between IL-2Rα-/- vs. wild-type mice, and sexes in three colonic locations. Imaged colon segments were analyzed ex vivo for inflammatory changes on H&E-stained sections and for selectin expression by immunofluorescence staining. We successfully detected spontaneous chronic colitis in IL-2Rα-/- mice between 6-30 weeks (onset at 6-14 weeks) compared to wild-type mice. Both male and female IL-2Rα-/- mice were equally (p = 0.996) affected with the disease, and there was no significant (p > 0.05) difference in USMI signals of colitis between the proximal, middle, and distal colon. We observed the fluctuating USMI signals in IL-2Rα-/- mice between 6-30 weeks, which might suggest a resemblance of the remission-flare pattern of human IBD. The ex vivo H&E and immunostaining further confirmed the inflammatory changes, and the high expression of P- and E-selectin in the colon. The results of this study highlight the IL-2Rα-/- mice as a chronic colitis model and are suitable for the long-term assessment of treatment response using a dual P- and E-selectin-targeted USMI.
Keywords: E-selectin; P-selectin; chronic disease; colitis; flare; inflammatory bowel disease (IBD); interleukin 2 receptor α deficient (IL-2Rα−/−) mice; remission; transgenic mouse model; ultrasound molecular imaging (USMI).
Conflict of interest statement
The authors have declared that no competing interest exists.
Figures
Similar articles
-
Chronic Model of Inflammatory Bowel Disease in IL-10-/- Transgenic Mice: Evaluation with Ultrasound Molecular Imaging.Theranostics. 2019 Aug 14;9(21):6031-6046. doi: 10.7150/thno.37397. eCollection 2019. Theranostics. 2019. PMID: 31534535 Free PMC article.
-
Assessment of Inflammation in an Acute on Chronic Model of Inflammatory Bowel Disease with Ultrasound Molecular Imaging.Theranostics. 2015 Aug 8;5(11):1175-86. doi: 10.7150/thno.13048. eCollection 2015. Theranostics. 2015. PMID: 26379784 Free PMC article.
-
Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.Invest Radiol. 2015 May;50(5):322-9. doi: 10.1097/RLI.0000000000000128. Invest Radiol. 2015. PMID: 25575176 Free PMC article.
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
-
Lessons from genetic models of inflammatory bowel disease.Acta Gastroenterol Belg. 1997 Apr-Jun;60(2):163-5. Acta Gastroenterol Belg. 1997. PMID: 9260328 Review.
Cited by
-
Dual role of CD177 + neutrophils in inflammatory bowel disease: a review.J Transl Med. 2024 Sep 2;22(1):813. doi: 10.1186/s12967-024-05539-3. J Transl Med. 2024. PMID: 39223577 Free PMC article. Review.
References
-
- Ng S.C., Shi H.Y., Hamidi N., Underwood F.E., Tang W., Benchimol E.I., Panaccione R., Ghosh S., Wu J.C.Y., Chan F.K.L., et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2018;390:2769–2778. doi: 10.1016/S0140-6736(17)32448-0. - DOI - PubMed
-
- Martinez-Montiel M.P., Casis-Herce B., Gomez-Gomez G.J., Masedo-Gonzalez A., Yela-San Bernardino C., Piedracoba C., Castellano-Tortajada G. Pharmacologic therapy for inflammatory bowel disease refractory to steroids. Clin. Exp. Gastroenterol. 2015;8:257–269. doi: 10.2147/CEG.S58152. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
